Cardiogenic Shock
225
74
80
63
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Research Maturity
63 completed trials (28% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.1%
7 terminated out of 225 trials
90.0%
+3.4% vs benchmark
10%
23 trials in Phase 3/4
8%
5 of 63 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 63 completed trials
Clinical Trials (225)
Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock
Capital Offload-Shock
Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients
Clinical Evaluation of NIRSense Tissue Oximetry Sensor Monitoring to Early Detect Cardiogenic Shock
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
Hong Kong Cardiogenic Shock Initiative
Optimal Timing of Microaxial Flow Pump(Impella CP) in AMI-related Cardiogenic Shock
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Catheter-Oriented Unloading and Recovery With a Left Ventricular Assist Gear: Efficacy in Post Cardiotomy Cardiogenic Shock
Cardiac Rehabilitation in Patients Acutely Managed for Cardiogenic Shock (ENIGMA)
Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock
Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
Prognostic Value Enhancement Of Sequential Organ Failure Assessment )SOFA( Score by Neutrophil-Lymphocyte Ratio and Red Cell Distribution Width in Cardiogenic Shock Patients.
Safety and Efficacy of the Extracorporeal Ventricular Assist System in Car Diogenic Shock: A Prospective, Multicenter , Single-Arm Study
CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
COMPARE-VENT Feasibility Pilot Study